CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Option exercise 10b5-1 | +2,000 | 39,394 | ||
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −594 | $28.96 | $17K | 38,800 |
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Option exercise 10b5-1 | +5,666 | 44,466 | ||
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −1,681 | $28.96 | $49K | 42,785 |
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Option exercise 10b5-1 | +4,000 | 46,785 | ||
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 45,598 |
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Option exercise 10b5-1 | +5,303 | 50,901 | ||
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −1,573 | $28.96 | $46K | 49,328 |
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Option exercise · Restricted stock units 10b5-1 | −2,000 | 0 | ||
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Option exercise · Restricted stock units 10b5-1 | −5,666 | 5,667 | ||
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Option exercise · Restricted stock units 10b5-1 | −4,000 | 8,000 | ||
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Option exercise · Restricted stock units 10b5-1 | −5,303 | 10,607 | ||
| 2026-03-02 | Milanova Tsveta Chief Commercial Officer | Option exercise 10b5-1 | +5,666 | 40,459 | ||
| 2026-03-02 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −1,681 | $28.96 | $49K | 38,778 |
| 2026-03-02 | Milanova Tsveta Chief Commercial Officer | Option exercise 10b5-1 | +4,000 | 42,778 | ||
| 2026-03-02 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 41,591 |
| 2026-03-02 | Milanova Tsveta Chief Commercial Officer | Option exercise · Restricted stock units 10b5-1 | −5,666 | 5,667 | ||
| 2026-03-02 | Milanova Tsveta Chief Commercial Officer | Option exercise · Restricted stock units 10b5-1 | −4,000 | 8,000 | ||
| 2026-03-02 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise 10b5-1 | +2,350 | 3,293 | ||
| 2026-03-02 | Washburn Theodore James Jr. Principal Accounting Officer | Sale 10b5-1 | −698 | $28.96 | $20K | 2,595 |
Page 7 of 48 · 941 trades